Global Retinal Disorder Treatment Market Report 2023 to 2030: Increasing Prevalence of Target Diseases Drives Growth
March 14, 2023 12:18 ET
|
Research and Markets
Dublin, March 14, 2023 (GLOBE NEWSWIRE) -- The "Retinal Disorder Treatment Market Size, Share & Trends Analysis Report By Type (Macular Degeneration, Diabetic Retinopathy), By Dosage Form, By...
Fundus Camera Global Market Report 2023: Increasing Number of Product Launches by Key Players is Expected to Propel Growth
March 01, 2023 09:48 ET
|
Research and Markets
Dublin, March 01, 2023 (GLOBE NEWSWIRE) -- The "Fundus Camera Market, by Product Type, by Modality, by End User, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030" report...
Clinical trials results demonstrate value of home OCT at international meetings
February 22, 2023 08:00 ET
|
Notal Vision
Manassas, VA, Feb. 22, 2023 (GLOBE NEWSWIRE) -- Notal Vision, Inc. reported today that the latest data on its investigational home-based optical coherence tomography (OCT) and how the service can be...
Kinarus Therapeutics Phase 2 KINFAST Covid-19 Clinical Trial Progress Update
February 21, 2023 01:00 ET
|
Kinarus Therapeutic Holding AG
KINFAST is evaluating KIN001 for reduction in severity and duration of Covid-19 symptomsKINFAST is actively enrolling in Germany/Switzerland Basel, Switzerland, 20 February 2023. Kinarus Therapeutics...
Age-Related Macular Degeneration (AMD) Global Market Report 2022: Featuring F. Hoffman - La Roche, Bayer, Abbvie, GSK, Novartis, Regeneron Pharmaceuticals, Bausch Health & Alimera Sciences
January 24, 2023 04:48 ET
|
Research and Markets
Dublin, Jan. 24, 2023 (GLOBE NEWSWIRE) -- The "Age-Related Macular Degeneration (AMD) Market, Global Forecast 2023-2028, Industry Trends, Growth, Impact of Inflation, Opportunity Company Analysis"...
Kinarus Therapeutics Reports Preclinical Data in Lung Fibrosis and Discloses Clinical Development Plan
January 17, 2023 01:00 ET
|
Kinarus Therapeutic Holding AG
KIN001 reduced fibrotic damage of the lung in a preclinical fibrosis modelPotential as an effective oral therapy for Idiopathic Pulmonary Fibrosis (IPF)Phase 2 clinical trial in IPF patients in...
Macular Degeneration (AMD) and Other Retinal Diseases Drugs market is projected to grow at a CAGR of 10.74% by 2032: Visiongain Reports Ltd
January 09, 2023 09:00 ET
|
Visiongain Reports Ltd
Visiongain has published a new report entitled Macular Degeneration (AMD) and Other Retinal Diseases Drugs 2022-2032. It includes profiles of Macular Degeneration (AMD) and Other Retinal Diseases...
$156.3+ Billion Worldwide Eyewear Industry to 2031 - Increasing Cases of Deteriorating Eye Health Drives Growth
January 09, 2023 06:33 ET
|
Research and Markets
Dublin, Jan. 09, 2023 (GLOBE NEWSWIRE) -- The "Eyewear Global Market Report 2022" report has been added to ResearchAndMarkets.com's offering. This report provides strategists, marketers and...
Kinarus Therapeutics’ KIN001 Shows Strong Antiviral Activity Against SARS-CoV-2 Omicron Subvariants BA.2 and BA.5
December 06, 2022 01:00 ET
|
Kinarus Therapeutic Holding AG
Kinarus Therapeutics’ KIN001 Shows Strong Antiviral Activity Against SARS-CoV-2 Omicron Subvariants BA.2 and BA.5 Researchers at Friedrich-Alexander-Universität Erlangen-Nürnberg and Kinarus report...
Global Age-related Macular Degeneration Market Report 2022 to 2030: High R&D Investments, Product Launches, Rising Age-Related Macular Degeneration (AMD) Prevalence are Driving Growth
December 02, 2022 06:23 ET
|
Research and Markets
Dublin, Dec. 02, 2022 (GLOBE NEWSWIRE) -- The "Age-related Macular Degeneration Market Size, Share & Trends Analysis Report by Product (Eylea, Lucentis, Beovu), by Disease Type (Wet AMD, Dry...